Edmonds Amy 4
4 · Bellerophon Therapeutics, Inc. · Filed Sep 30, 2019
Insider Transaction Report
Form 4
Edmonds Amy
VP Clinical Operations & Admin
Transactions
- Award
Stock Option (right to buy)
2019-09-26+175,500→ 445,886 totalExercise: $0.50Exp: 2029-09-26→ Common Stock (175,500 underlying)
Footnotes (1)
- [F1]1. This option was granted on September 26, 2019. This option vests in quarterly installments over a four-years period from the date of grant.